Circulating microRNAs indicate cardioprotection by sevoflurane inhalation in patients undergoing off-pump coronary artery bypass surgery

Experimental and Therapeutic Medicine

Volumn 11, Issue 6, 2016, Pages 2270-2276

  Liu, Xiao ^a   Liu, Xiaopeng ^a   Wang, Ruike ^a   Luo, Hui ^a   Qin, Gang ^a   Wang, Lu ^a   Ye, Zhi ^a   Guo, Qulian ^a   Wang, E ^a  

^a CENTRAL SOUTH UNIVERSITY   (China)

Author keywords

Cardioprotection; Circulating microRNAs; Off pump coronary artery bypass surgery; Sevoflurane

Indexed keywords

CREATINE KINASE MB; ESMOLOL; GLYCERYL TRINITRATE; LACTATE DEHYDROGENASE; METOPROLOL; MEVINOLIN; MICRORNA; MICRORNA 208B; MICRORNA 499; MORPHINE; PHENYLEPHRINE; PROPOFOL; SCOPOLAMINE; SEVOFLURANE; SUFENTANIL; TROPONIN I; UNCLASSIFIED DRUG; VECURONIUM;

ADULT; AGED; ANESTHESIA INDUCTION; ANESTHESIA LEVEL; ARTICLE; BISPECTRAL INDEX; CENTRAL VENOUS PRESSURE; CLINICAL ARTICLE; CONTROLLED STUDY; CORE TEMPERATURE; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HEART MUSCLE INJURY; HEART OUTPUT; HEART PROTECTION; HEART RATE; HEART STROKE VOLUME; HEMODYNAMIC PARAMETERS; HUMAN; LUNG WEDGE PRESSURE; MALE; MEAN ARTERIAL PRESSURE; MINIMUM LUNG ALVEOLUS CONCENTRATION; OFF PUMP CORONARY SURGERY; PULMONARY ARTERY MEAN PRESSURE;

EID: 84964068279     PISSN: 17920981     EISSN: 17921015     Source Type: Journal    
DOI: 10.3892/etm.2016.3197     Document Type: Article

References (53)

1. Parissis H, Mbarushimana S, Ramesh BC, Parissis M, Lampridis S, Mhandu P and Al-Alao B: The impact of off-pump surgery in end-organ function: Practical end-points. J Cardiothorac Surg 10: 158, 2015.
2. Gonenc A, Hacişevki A, Griffiths HR, Torun M, Bakkaloglu B and Simsek B: Free radical reaction products and antioxidant capacity in beating coronary artery surgery compared to conventional bypass. Biochemistry (Mosc) 76: 677-685, 2011.
3. Leslie JB: Incidence and aetiology of perioperative hypertension. Acta Anaesthesiol Scand Suppl 99: 5-9, 1993.
4. Yao YT, Fang NX, Shi CX and Li LH: Sevoflurane postconditioning protects isolated rat hearts against ischemia-reperfusion injury. Chin Med J (Engl) 123: 1320-1328, 2010.
5. Coetzee JF, Roux PJ, Genade S and Lonchner A: Reduction of postischemic contractile dysfunction of the isolated rat heart by sevoflurane: Comparison with halothane. Anesth Analg 90: 1089-1097, 2000.
6. De Hert SG, Broecke PW, Mertens E, Van Sommeren EW, De Blier IG, Stockman BA and Rodrigus IE: Sevoflurane but not propofol preserves myocardial function in coronary surgery patients. Anesthesiology 97: 42-49, 2002.
7. De Hert SG, Van der Linden PJ, Cromheecke S, Meeus R Nelis A, Van Reeth V, ten Broecke PW, De Blier IG, Stockman BA and Rodrigus IE: Cardioprotective properties of sevoflurane in patients undergoing coronary surgery with cardiopulmonary bypass are related to the modalities of its administration. Anesthesiology 101: 299-310, 2004.
8. Haroun-Bizri S, Khoury SS, Chehab IR, Kassas CM and Baraka A: Does isoflurane optimize myocardial protection during cardiopulmonary bypass? J Cardiothorac Vasc Anesth 15: 418-421, 2001.
9. Julier K, daSilva R, Garcia C, Bestmann L, Frascarolo P, Zollinger A, Chassot PG, Schmid ER, Turina MI, von Segesser LK, et al: Preconditioning by sevoflurane decreases biochemical markers for myocardial and renal dysfunction in coronary artery bypass graft surgery: A double-blinded, placebo-controlled, multicenter study. Anesthesiology 98: 1315-1327, 2003.
10. Fisher LA, Beckman JA, Brown KA, Calkins H, Chaikof E, Fleischmann KE, Freeman WK, Froehlich JB, Kasper EK, Kersten JR, et al: ACC/AHA 2007 guidelines on perioperative cardiovascular evaluation and care for noncardiac surgery: A report of the American college of cardiology/American heart association task force on practice guidelines. Circulation 116: e418-e499, 2007.
11. Landoni G, Bignami E, Oliviero F and Zangrillo A: Halogenated anaedthetics and cardiac protection in cardiac and non-cardiac anesthesia. Ann Card Anesth 12: 4-9, 2009.
12. Landoni G, Biondi-Zoccai GG, Zangrillo A, Bignami E, D'Avolio S, Marchetti C, Calabrò MG, Fochi O, Guarracino F, Tritapepe L, et al: Desflurane and sevoflurane in cardiac surgery: A meta-analysis of randomized clinical trials. J Cardiothorac Vasc Anesth 21: 502-511, 2007.
13. Hamm CW, Goldmann BU, Heeschen C, Kreymann G, Berger J and Meinertz T: Emergency room triage of patients with acute chest based on rapid testing for troponin T or troponin I. N Engl J Med 337: 1648-1653, 1997.
14. Davies E, Gawad Y, Takahashi M, Shi Q, Lam P, Styba G, Lau A, Heeschen C, Usategui M and Jackowski G: Analytical performance and clinical utility of a sensitive immunoassay for determination of human cardiac troponin I. Clin Biochem 30: 479-490, 1997.
15. Lewandrowski K, Chen A and Januzzi J: Cardiac markers for myocardial infarction. Am J Clin Pathol 118 (Suppl): S93-S99, 2002.
16. Dekker MS, Mosterd A, van't Hof AW and Hoes AW: Novel biochemical markers in suspected acute coronary syndrome: Systematic review and critical appraisal. Heart 96: 1001-1010, 2010.
17. Lewis BP, Shih IH, Jones-Rhoades MW, Bartel DP and Burge CB: Prediction of mammalian microRNA targets. Cell 115: 787-798, 2003.
18. Sluijter JP, van Mil A, van Vliet P, Metz CH, Liu J, Doevendans PA and Goumans MJ: MicroRNA-1 and -499 regulate differentiation and proliferation in human-derived cardiomyocyte progenitor cells. Arterioscler Thromb Vasc Biol 30: 859-868, 2010.
19. van Rooij E, Sutherland LB, Liu N, Williams AH, McAnally J, Gerard RD, Richardson JA and Olson EN: A signature pattern of stress-responsive microRNAs that can evoke cardiac hypertrophy and heart failure. Proc Natl Acad Sci USA 103: 18255-18260, 2006.
20. Oerlemans MI, Mosterd A, Dekker MS, de Vrey EA, van Mil A, Pasterkamp G, Doevendans PA, Hoes AW and Sluijter JP: Early assessment of acute coronary syndromes in the emergency department: The potential diagnostic value of circulating microRNAs. EMBO Mol Med 4: 1176-1185, 2012.
21. Devaux Y, Vausort M, Goretti E, Nazarov PV, Azuaje F, Gilson G, Corsten MF, Schroen B, Lair ML and Heymans S: Use of circulating microRNAs to diagnose acute myocardial infarction. Clin Chem 58: 559-567, 2012.
22. Lequin RM: Enzyme immunoassay (EIA)/enzyme-linked immunosorbent assay (ELISA). Clin Chem 51: 2415-2418, 2005.
23. Livak KJ and Schmittgen TD: Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods 25: 402-408, 2001.
24. Qiao S, Xie H, Wang C, Wu X, Liu H and Liu C: Delayed anesthetic preconditioning protects against myocardial infarction via activation of nuclear factor-κB and upregulation of autophagy. J Anesth 27: 251-260, 2013.
25. Torina AG, Reichert K, Lima F, de Souza Vilarinho KA, de Oliveira PP, do CarmoHR, de CarvalhoDD, SaadMJ, SpositoAC and Petrucci O: Diacerein improves left ventricular remodeling and cardiac function by reducing the inflammatory response after myocardial infarction. PLoS One 10: e0121842, 2015.
26. Wu X, He L, Chen F, He X, Cai Y, Zhang G, Yi Q, He M and Luo J: Impaired autophagy contributes to adverse cardiac remodeling in acute myocardial infarction. PLoS One 9: e112891, 2014.
27. Liu Q: Lentivirus mediated interference of Caspase-3 expression ameliorates the heart function on rats with acute myocardial infarction. Eur Rev Med Pharmacol Sci 18: 1852-1858, 2014.
28. Zhao J, Wang F, Zhang Y, Jiao L, Lau WB, Wang L, Liu B, Gao E, Koch WJ and Ma XL: Sevoflurane preconditioning attenuates myocardial ischemia/reperfusion injury via caveolin-3-dependent cyclooxygenase-2 inhibition. Circulation 128 (11) Suppl 1: S121-S129, 2013.
29. Yao YY, Zhu MH, Zhang FJ, Wen CY, Ma LL, Wang WN, Wang CC, Liu XB, Yu LN, Qian LB, et al: Activation of Akt and cardioprotection against reperfusion injury are maximal with only five minutes of sevoflurane post-conditioning in isolated rat hearts. J Zhejiang Univ Sci B 14: 511-517, 2013.
30. Zaugg M, Wang L, Zhang L, Lou PH, Lucchinetti E and Clanachan AS:Choiceof anesthetic combinationdeterminesCa2+ leak after ischemia-reperfusion injury in the working rat heart: Favorable versus adverse combinations. Anesthesiology 116: 648-657, 2012.
31. Samir A, Gandreti N, Madhere M, Khan A, Brown M and Loomba V: Anti-inflammatory effects of propofol during cardiopulmonary bypass: A pilot study. Ann Card Anaesth 18: 495-501, 2015.
32. Xia WF, Liu Y, Zhou QS, Tang QZ and Zou HD: Protective effect of propofol and its relation to postoperation recovery in children undergoing cardiac surgery with cardiopulmonary bypass. Pediatr Cardiol 32: 940-946, 2011.
33. Jovic M, Stancic A, Nenadic D, Cekic O, Nezic D, Milojevic P, Micovic S, Buzadzic B, Korac A, Otasevic V, et al: Mitochondrial molecular basis of sevoflurane and propofol cardioprotection in patients undergoing aortic valve replacement with cardiopulmonary bypass. Cell Physiol Biochem 29: 131-142, 2012.
34. Ballester M,Llorens J,Garcia-de-la-Asuncion J,Perez-Griera J,Tebar E,Martinez-Leon J,Belda J andJuez M:Myocardial oxidative stress protection by sevoflurane vs. propofol: A randomised controlled study in patients undergoing off-pump coronary artery bypass graft surgery. Eur J Anaesthesiol 28: 874-881, 2011.
35. El Azab SR, Scheffer GJ, Rosseel PM and De Lange JJ: Induction and maintenance of anaesthesia with sevoflurane in comparison to high dose opioid during coronary artery bypass surgery. Eur J Anaesthesiol 17: 336-338, 2000.
36. Futterman LG and Lemberg L: SGOT, LDH, HBD, CPK, CK-MB, MB1MB2, cTnT, cTnC, cTnI. Am J Crit Care 6: 333-338, 1997.
37. Law-Koune JD, Raynaud C, Liu N, Dubois C, Romano M and Fischler M: Sevoflurane-remifentanyl versus propofol-remifentanyl anesthesia at a similar bispectral level for off-pump coronary artery surgery: No evidence of reduced myocardial ischemia. J Cardiothorac Vasc Anesth 20: 484-492, 2006.
38. Hemmerling T, Olivier J, Le N, Prieto I and Bracco D: Myocardial protection by isoflurane vs. sevoflurane in ultra-fast-track anaesthesia for off-pump aortocoronary bypass grafting. Eur J Anaesthesiol 25: 230-236, 2008.
39. Conzen PF, Fischer S, Detter C and Peter K: Sevoflurane provides greater protection of the myocardium than propofol in patients undergoing off-pump coronary artery bypass surgery. Anesthesiology 99: 826-833, 2003.
40. Riess ML, Kevin LG, Camara AK, Heisner JS and Stowe DF: Dual exposure to sevoflurane improves anesthetic preconditioning in intact hearts. Anesthesiology 100: 569-574, 2004.
41. Piriou V, Mantz J, Goldfarb G, Kitakaze M, Chiari P, Paquin S, Cornu C, Lecharny JB, Aussage P, Vicaut E, et al: Sevoflurane preconditioning at 1 MAC only provides limited protection in patients undergoing coronary artery bypass surgery: A randomized bi-centre trial. Br J Anaesth 99: 624-631, 2007.
42. Vikenes K, Andersen KS, Melberg T, Farstad M and Nordrehaug JE: Long-term prognostic value of cardiac troponin I and T versus creatine kinase-MB mass after cardiac surgery in low-risk patients with stable symptoms. Am J Cardiol 106: 780-786, 2010.
43. Ekaney ML, Otto GP, Sossdorf M, Sponholz C, Boehringer M, Loesche W, Rittirsch D, Wilharm A, Kurzai O, Bauer M and Claus RA: Impact of plasma histones in human sepsis and their contribution to cellular injury and inflammation. Crit Care 18: 543, 2014.
44. De Rosa S and Indolfi C: Circulating microRNAs as Biomarkers in Cardiovascular Diseases. EXS 106: 139-149, 2015.
45. Schulte C, Molz S, Appelbaum S, Karakas M, Ojeda F, Lau DM, Hartmann T, Lackner KJ, Westermann D, Schnabel RB, et al: miRNA-197 and miRNA-223 Predict Cardiovascular Death in a Cohort of Patients with Symptomatic Coronary Artery Disease. PLoS One 10: e0145930, 2015.
46. Ji X, Takahashi R, Hiura Y, Hirokawa G, Fukushima Y and Iwai N: Plasma miR-208 as a biomarker of myocardial injury. Clin Chem 55: 1944-1949, 2009.
47. Reddy A, Zheng Y, Jagadeeswaran G, Macmil SL Graham WB, Roe BA, Desilva U, Zhang W and Sunkar R: Cloning, characterization and expression analysis of porcine microRNAs. BMC genomics 10: 65, 2009.
48. Gidlöf O, Andersson P, van der Pals J, Götberg M and Erlinge D: Cardiospecific microRNA plasa levels correlate with troponin and cardiac function in patients with ST elevation myocardial infarction, are selectively dependent on renal elimination and can be detected in urine samples. Cardiology 118: 217-226, 2011.
49. Olivieri F, Antonicelli R, Lorenzi M, D'Alessandra Y, Lazzarini R, Santini G, Spazzafumo L, Lisa R, La Sala L, Galeazzi R, et al: Diagnostic potential of circulating miR-499-5p in elderly patients with acute non ST-elevation myocardial infarction. Int J Cardiol 167: 531-536, 2013.
50. Gidlof O, Smith JG, Miyazu K, Gilje P, Spencer A, Blomquist S and Erlinge D: Circulating cardio-enriched microRNAs are associated with long-term prognosis following myocardial infarction. BMC Cardiovasc Disord 13: 12, 2013.
51. Corsten MF, Dennert R, Jochems S, Kuznetsova T, Devaux Y, Hofstra L, Wagner DR, Staessen JA, Heymans S and Schroen B: Circulating MicroRNA-208b and MicroRNA-499 reflect myocardial damage in cardiovascular disease. Circ Cardiovasc Genet 3: 499-506, 2010.
52. Ishikawa M, Tanaka S, Arai M, Genda Y and Sakamoto A: Differences in microRNA changes of healthy rat liver between sevoflurane and propofol anesthesia. Anesthesiology 117: 1245-1252, 2012.
53. Tanaka S, Ishikawa M, Arai M, Genda Y and Sakamoto A: Changes in microRNA expression in rat lungs caused by sevoflurane anesthesia: A TaqMan® low-density array study. Biomed Res 33: 255-263, 2012.